Event-Driven Stocks

TENGION INC

Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕

Signs2 good2 warning2 severedetails ↓

Financials

SEC XBRL · annual
 FY13FY12FY11FY10
Revenue$0$0$0
Operating income
Net income−$217.7M−$16.9M−$19.1M−$25.6M
Total assets$25.7M$12.4M$17.8M$24.1M
Total liabilities$42.6M$23.8M$12.8M$13.1M
Equity−$16.9M−$11.3M$5.0M$11.1M
EPS (diluted)
Shares out.3.1M24.3M2.4M12.4M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2013
Operating margin
Net margin
Return on equity
1291.6%
Return on assets
−846.3%
Return on capital (ROCE)
Liabilities / assets
165.5%
Debt / equity
Book value / share
$-5.40
Revenue growth (YoY)
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2013
Accruals / assets
96.8%clean
Piotroski F-Score
4/8mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
46
/ 100
Profitability 50Growth n/aCatalyst 33Earnings quality 67Financial strength 33

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

2 severe2 warning2 good
  • Negative shareholder equity
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Strong return on equity (>15%)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Insider transactions

SEC Form 4 · most recent
1 acquisitions4 disposalsnet 6,660 shares · last 5
InsiderDateTypeSharesPrice
Miclot John LOfficer — President and CEOJan 3, 2014Tax withholding3,622$0.23
Randall LorinDirectorApr 14, 2010Conversion379
Bertram TimothyOfficer — Pres Rsrch &amp; Dev, &amp; Chf Sc OfcMar 4, 2013Tax withholding325$1.25
Miclot John LOfficer — President and CEOMar 4, 2013Tax withholding2,913$1.25
Davis A BrianOfficer — Chf. Fin. Offr, VP Fin.Mar 4, 2013Tax withholding179$1.25

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)